Capillary Biomedical Reports Best-in-Class Clinical Feasibility Results for its SteadiFlow Seven-Day-Wear Infusion Set Technology at ADA Scientific Sessions

IRVINE, Calif.--(BUSINESS WIRE)-- #ADA--Capillary Biomedical reported best-in-class clinical feasibility results for its SteadiFlow 7-day-wear infusion set technology at ADA.

Click to view original post